Literature DB >> 10366480

Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin.

T D Le1, S D Yamada, J L Rutgers, P J DiSaia.   

Abstract

Uterine papillary serous carcinoma (UPSC) is an aggressive histologic subtype of endometrial cancer. Currently, no effective chemotherapy regimens exist. We report a case of complete response of a stage IV UPSC to neoadjuvant chemotherapy with Taxol and carboplatin. Copyright 1999 Academic Press.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10366480     DOI： 10.1006/gyno.1999.5361

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


  7 in total

1.  Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma.

Authors:  Ivy Wilkinson-Ryan; Antonina I Frolova; Jingxia Liu; L Stewart Massad; Premal H Thaker; Matthew A Powell; David G Mutch; Andrea R Hagemann
Journal:  Int J Gynecol Cancer       Date:  2015-01       Impact factor: 3.437

2.  Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma.

Authors:  Chad M Michener; Gertrude Peterson; Barbara Kulp; Kenneth D Webster; Maurie Markman
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

3.  Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel.

Authors:  Dana M Roque; Natalia Buza; Michelle Glasgow; Stefania Bellone; Ileana Bortolomai; Sara Gasparrini; Emiliano Cocco; Elena Ratner; Dan-Arin Silasi; Masoud Azodi; Thomas J Rutherford; Peter E Schwartz; Alessandro D Santin
Journal:  Clin Exp Metastasis       Date:  2013-09-05       Impact factor: 5.150

4.  Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer.

Authors:  N M de Lange; N P M Ezendam; J S Kwon; I Vandenput; D Mirchandani; F Amant; L J M van der Putten; J M A Pijnenborg
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

5.  Analysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients.

Authors:  Reiko Numazaki; Etsuko Miyagi; Katsuyuki Konnai; Masae Ikeda; Akihito Yamamoto; Ryo Onose; Hisamori Kato; Naoyuki Okamoto; Fumiki Hirahara; Hiroki Nakayama
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

6.  Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?

Authors:  I Vandenput; B Van Calster; A Capoen; K Leunen; P Berteloot; P Neven; Ph Moerman; I Vergote; F Amant
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

7.  Clinicopathologic study in uterine cancer.

Authors:  I Vandenput
Journal:  Facts Views Vis Obgyn       Date:  2011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.